Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Jun;94(2):285–287. doi: 10.1111/j.1476-5381.1988.tb11527.x

The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.

A J Stoessl 1, C T Dourish 1, S D Iversen 1
PMCID: PMC1853993  PMID: 2456111

Abstract

The behavioural effects of the selective NK-3 tachykinin receptor agonist senktide were studied following intracisternal and subcutaneous administration in rodents. Behavioural manifestations of 5-hydroxytryptaminergic stimulation, including head twitches (mice), wet dog shakes (rats), forepaw treading, flat body posture, hindlimb splaying and Straub tail, were seen following the intracisternal (0.01-1.2 nmol) or subcutaneous (0.1-2.4 mumol kg-1) administration of senktide in both species. We conclude that stimulation of NK-3 receptors stimulates 5-hydroxytryptaminergic pathways in rodent brain, and that senktide may cross the blood-brain barrier in biologically significant amounts.

Full text

PDF
285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnati L. F., Fuxe K., Benfenati F., Zini I., Hökfelt T. On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites. Acta Physiol Scand. 1983 Feb;117(2):299–301. doi: 10.1111/j.1748-1716.1983.tb07210.x. [DOI] [PubMed] [Google Scholar]
  2. Chan-Palay V., Jonsson G., Palay S. L. Serotonin and substance P coexist i, neurons of the rat's central nervous system. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1582–1586. doi: 10.1073/pnas.75.3.1582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Forchetti C. M., Marco E. J., Meek J. L. Serotonin and gamma-aminobutyric acid turnover after injection into the median raphe of substance P and D-ala-met-enkephalin amide. J Neurochem. 1982 May;38(5):1336–1341. doi: 10.1111/j.1471-4159.1982.tb07910.x. [DOI] [PubMed] [Google Scholar]
  4. Hökfelt T., Ljungdahl A., Steinbusch H., Verhofstad A., Nilsson G., Brodin E., Pernow B., Goldstein M. Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience. 1978;3(6):517–538. doi: 10.1016/0306-4522(78)90017-9. [DOI] [PubMed] [Google Scholar]
  5. Mitchell R., Fleetwood-Walker S. Substance P, but not TRH, modulates the 5-HT autoreceptor in ventral lumbar spinal cord. Eur J Pharmacol. 1981 Nov 19;76(1):119–120. doi: 10.1016/0014-2999(81)90020-0. [DOI] [PubMed] [Google Scholar]
  6. Mâgoul R., Onteniente B., Oblin A., Calas A. Inter- and intracellular relationship of substance P-containing neurons with serotonin and GABA in the dorsal raphe nucleus: combination of autoradiographic and immunocytochemical techniques. J Histochem Cytochem. 1986 Jun;34(6):735–742. doi: 10.1177/34.6.2422252. [DOI] [PubMed] [Google Scholar]
  7. Neckers L. M., Schwartz J. P., Wyatt R. J., Speciale S. G. Substance P afferents from the habenula innervate the dorsal raphe nucleus. Exp Brain Res. 1979;37(3):619–623. doi: 10.1007/BF00236830. [DOI] [PubMed] [Google Scholar]
  8. Reisine T., Soubrie P., Artaud F., Glowinski J. Application of L-glutamic acid and substance P to the substantia nigra modulates in vivo [3H]serotonin release in the basal ganglia of the cat. Brain Res. 1982 Mar 25;236(2):317–327. doi: 10.1016/0006-8993(82)90717-x. [DOI] [PubMed] [Google Scholar]
  9. Reubi J. C., Emson P. C., Jessell T. M., Iversen L. L. Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;304(3):271–275. doi: 10.1007/BF00507968. [DOI] [PubMed] [Google Scholar]
  10. Solti M., Bartfai T. Tachykinin regulation of serotonin release: enhancement of [3H]serotonin release from rat cerebral cortex by neuromedin K and substance P acting at distinct receptor sites. Brain Res. 1987 Jan 20;401(2):377–380. doi: 10.1016/0006-8993(87)91424-7. [DOI] [PubMed] [Google Scholar]
  11. Stoessl A. J., Dourish C. T., Young S. C., Williams B. J., Iversen S. D., Iversen L. L. Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse. Neurosci Lett. 1987 Oct 5;80(3):321–326. doi: 10.1016/0304-3940(87)90475-7. [DOI] [PubMed] [Google Scholar]
  12. Wormser U., Laufer R., Hart Y., Chorev M., Gilon C., Selinger Z. Highly selective agonists for substance P receptor subtypes. EMBO J. 1986 Nov;5(11):2805–2808. doi: 10.1002/j.1460-2075.1986.tb04571.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES